Minocycline Inhibits Tick-Borne Encephalitis Virus and Protects Infected Cells via Multiple Pathways
Viruses · 2024
DOI: 10.3390/v16071055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Mengtao Cao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Disease Control and Prevention of Southern Theater Command, Guangzhou 510507, China. Hauptthemen laut MEDLINE: Encephalitis Viruses, Tick-Borne, Minocycline, Virus Replication. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Province Science and Technology Library, Guangdong Province science and technology project.
Abstract (Originalsprache)
Tick-borne Encephalitis (TBE) is a zoonotic disease caused by the Tick-borne Encephalitis virus (TBEV), which affects the central nervous system of both humans and animals. Currently, there is no specific therapy for patients with TBE, with symptomatic treatment being the primary approach. In this study, the effects of minocycline (MIN), which is a kind of tetracycline antibiotic, on TBEV propagation and cellular protection in TBEV-infected cell lines were evaluated. Indirect immunofluorescence, virus titers, and RT-qPCR results showed that 48 h post-treatment with MIN, TBEV replication was significantly inhibited in a dose-dependent manner. In addition, the inhibitory effect of MIN on different TBEV multiplicities of infection (MOIs) in Vero cells was studied. Furthermore, the transcriptomic analysis and RT-qPCR results indicate that after incubation with MIN, the levels of TBEV and CALML4 were decreased, whereas the levels of calcium channel receptors, such as RYR2 and SNAP25, were significantly increased. MIN also regulated MAPK-ERK-related factors, including FGF2, PDGFRA, PLCB2, and p-ERK, and inhibited inflammatory responses. These data indicate that administering MIN to TBEV-infected cells can reduce the TBEV level, regulate calcium signaling pathway-associated proteins, and inhibit the MAPK-ERK signaling pathway and inflammatory responses. This research offers innovative strategies for the advancement of anti-TBEV therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Disease Control and Prevention of Southern Theater Command, Guangzhou 510507, China.
- Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
- College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
- Instrument Analysis & Research Center, South China Agricultural University, Guangzhou 510642, China.
- Guangdong Arbovirus Diseases Emergency Technology Research Center, Guangzhou 510507, China.
ORCID-Profile: Yue Chen, Hongxia Jiang, Chunyuan Li
Förderung
- Guangdong Province Science and Technology Library
- Guangdong Province science and technology project
Zitieren
APA
Cao, M., Yang, W., Yang, J., Zhao, Y., Hu, X., Xu, X., Tian, J., Chen, Y., Jiang, H., Ren, R., & Li, C. (2024). Minocycline Inhibits Tick-Borne Encephalitis Virus and Protects Infected Cells via Multiple Pathways. Viruses. https://doi.org/10.3390/v16071055
Vancouver
Cao M, Yang W, Yang J, Zhao Y, Hu X, Xu X, et al. Minocycline Inhibits Tick-Borne Encephalitis Virus and Protects Infected Cells via Multiple Pathways. Viruses. 2024. doi:10.3390/v16071055
BibTeX
@article{Cao2024,
author = {Cao, Mengtao and Yang, Wei and Yang, Jintao and Zhao, Yanli and Hu, Xiaoyu and Xu, Xiaoli and Tian, Jing and Chen, Yue and Jiang, Hongxia and Ren, Ruiwen and Li, Chunyuan},
title = {Minocycline Inhibits Tick-Borne Encephalitis Virus and Protects Infected Cells via Multiple Pathways},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16071055}
}
EUVIMED